[DWYER, Michael, P., KEERTIKAR, Kartik, M., ZENG, Qingbei, MAZZOLA, Robert, D., Jr., CALDWELL, John, P., TANG, Haiqun, NAIR, Anilkumar Gopinadhan, SHANKAR, Bandarpalle, B., ROSENBLUM, Stuart, B., KOZLOWSKI, Joseph, A.] 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US

[NAIR ANILKUMAR GOPINADHAN, KIM SEONG HEON, ROSENBLUM STUART B, WONG MICHAEL K C, ZENG QINGBEI, KEERTIKAR KERRY M, KOZLOWSKI JOSEPH A, SELYUTIN OLEG B, YU WENSHENG] US

[NAIR ANILKUMAR GOPINADHAN, KEERTIKAR KERRY M, KIM SEONG HEON, KOZLOWSKI JOSEPH A, ROSENBLUM STUART, SELYUTIN OLEG B, WONG MICHAEL, YU WENSHENG, ZENG QINGBEI] US

[NAIR ANILKUMAR GOPINADHAN, KEERTIKAR KERRY, KIM SEONG HEON, KOZLOWSKI JOSEPH, ROSENBLUM STUART, SELYUTIN OLEG, WONG MICHAEL, YU WENSHENG, ZENG QINGBEI] US The present invention relates to novel Fused Tricyclic SiIyI Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, M, X and X are as defined herein. The present invention also relates to compositions comprising at least one Fused Tricyclic Silyl Compound, and methods of using the Fused Tricyclic Silyl Compounds for treating or preventing HCV infection in a patient.

[Qingbei Zeng, Kevin X. Chen, Anilkumar Gopinadhan Nair, Stuart B. Rosenblum, Joseph A. Kozlowski, F. George Njoroge] US NJ Edison The present invention relates to novel Linked Tricyclic Aryl Compounds, compositions comprising at least one Linked Tricyclic Compound, and methods of using Linked Tricyclic Aryl Compounds for treating or preventing HCV infection in a patient. in one aspect, the present invention provides Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein: Non-limiting examples of the Compounds of Formula (II) include compound 56.

[Kevin X. Chen, Anilkumar Gopinadhan Nair, Qingbei Zeng, Stuart B. Rosenblum, Joseph A. Kozlowski, F. George Njoroge] US NJ Edison The present invention relates to novel Tricyclic Compounds, compositions comprising at least one Tricyclic Compound, and methods of using Tricyclic Compounds for treating or preventing a viral infection or a virus-related disorder in a patient. The present invention provides Tricyclic Compounds of Formula (I): Non-limiting examples of the Compounds of Formula (I) include compound 44 The Compounds of Formula (II) can be useful for inhibiting HCV viral replication or replicon activity, and for treating or pre-venting HCV infection in a patient.

[KOZLOWSKI JOSEPH A, ZENG QINGBEI, ROSENBLUM STUART B, KIM SEONG-HEON, SELYUTIN OLEG B, NAIR ANILKUMAR GOPINADHAN, KEERTIKAR KERRY M, WONG MICHAEL, YU WENSHENG]

[Nair, Anilkumar Gopinadhan, Keertikar, Kerry M., Kim, Seong Heon, Kozlowski, Joseph A., Rosenblum, Stuart, Selyutin, Oleg B., Wong, Michael, Yu, Wensheng, Zeng, Qingbei] 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US

[DWYER, Michael, P., KEERTIKAR, Kartik, M., ZENG, Qingbei, MAZZOLA, Robert, D., Jr., CALDWELL, John, P., TANG, Haiqun, NAIR, Anilkumar Gopinadhan, SHANKAR, Bandarpalle, B., ROSENBLUM, Stuart, B., KOZLOWSKI, Joseph, A.] 126 East Lincoln Avenue Rahway, New Jersey 07065-0907;126 East Lincoln Avenue Rahway, New Jersey 07065-0907;126 East Lincoln Avenue Rahway, New Jersey 07065-0907;509 Cinder Road Edison, New Jersey 08820;126 East LIncoln Avenue Rahway, New Jersey 07065-0907;126 East Lincoln Avenue Rahway, New Jersey 07065-0907;126 East Lincoln Avenue Rahway, New Jersey 07065-0907;126 East Lincoln Avenue Rahway, New Jersey 07065-0907;1124 Van Arsdale Drive Branchburg, New Jersey 08853;16 Steven Terrace West Orange, New Jersey 07052;126 East Lincoln Avenue Rahway, New Jersey 07065-0907 The present invention relates to novel Silyl-Containing Heterocyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, B, C, D and R2 are as defined herein. The present invention also relates to compositions comprising at least one Silyl-Containing Heterocyclic Compound, and methods of using the Silyl-Containing Heterocyclic Compounds for treating or preventing HCV infection in a patient.

[NAIR ANILKUMAR GOPINADHAN, KEERTIKAR KERRY M, KIM SEONG HEON, KOZLOWSKI JOSEPH A, ROSENBLUM STUART, SELYUTIN OLEG B, WONG MICHAEL, YU WENSHENG, ZENG QINGBEI] US The present invention relates to novel Fused Tricyclic SiIyI Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, M1, X1 and X2 are as defined herein. The present invention also relates to compositions comprising at least one Fused Tricyclic Silyl Compound, and methods of using the Fused Tricyclic Silyl Compounds for treating or preventing HCV infection in a patient.